You are about to leave the Clinical Value website now.


HCC monitoring and surveillance update – the limbic

HCC monitoring and surveillance udpate (resize)

In these series of videos produced by the limbic, A/Prof. Simone Strasser and A/Prof. Jessica Howell discuss:

  • how changes in the epidemiology of advanced liver disease – both in Australia and globally – present challenges to the surveillance and monitoring of hepatocellular carcinoma
  • discuss ways that specialists can ensure at-risk patients are undergoing surveillance for HCC
  • current and future approaches to HCC surveillance and monitoring

Click the buttons below to watch the videos directly on the limbic:

The changing epidemiology of advanced liver disease and HCC

HCC surveillance in at-risk patients

Limitations of current HCC surveillance strategies and future solutions

You May Also Like

19 May 2023

Hepatocellular carcinoma surveillance and the emerging role of biomarker-based models

A/Prof Simone Strasser recently published an independent commentary in the Australian Medical Research and Journal "Research Review", covering at length topics such as non-alcoholic liver disease as an increasing risk…

Read More
15 June 2023

Moving towards risk-based surveillance and early detection of hepatocellular carcinoma

Read More
19 June 2023

HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: A meta-analysis

This systematic review and meta-analysis of cohort studies of patients with cirrhosis aimed to evaluate the benefit and harms of HCC surveillance in patients with cirrhosis. Singal AG, Zhang E,…

Read More


Be the first to receive updates, event opportunities, and thought leadership insights.